Regina M. Graul - 05 Aug 2024 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
President and Chief Executive Officer, Director
Signature
/s/ Regina M. Graul
Issuer symbol
CYCN
Transactions as of
05 Aug 2024
Net transactions value
$0
Form type
4
Filing time
07 Aug 2024, 16:05:04 UTC
Previous filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCN Stock Option (Right to Buy) Award $0 +55,849 $0.000000 55,849 05 Aug 2024 Common Stock 55,849 $3.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted an option to purchase up to 55,849 shares of the Corporation's common stock pursuant to the 2019 Equity Incentive Plan. These 55,849 shares vest ratably in monthly installments over a 48-month period commencing August 31, 2024 and ending July 31, 2028, provided that the Reporting Person remains employed by Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.

Remarks:

President and Chief Executive Officer